| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-10-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | $240.00K | $349.09K | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $1.50M | $2.57M | $1.76M | – | $1.32M | $317.59K |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | -$1.50M | -$2.57M | -$1.76M | – | -$1.32M | -$317.59K |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $13.00K | $80.00K | $132.00K | – | $314.00K | – |
| Net Income | -$1.41M | -$2.23M | -$1.15M | – | -$226.63K | -$314.97K |
| EPS (basic) | – | – | – | – | – | -0.0500 |
| EPS (diluted) | – | – | – | – | -0.0800 | -0.0500 |
| Shares (diluted) | – | – | – | – | $2.88M | $2.88M |